Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2000
12/14/2000WO2000075376A1 Hepg2 cells stably transfected with hcv
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075372A1 A process for preparing peptide nucleic acid probe using polymeric photoacid generator
12/14/2000WO2000075359A2 Gene encoding short integuments and uses thereof
12/14/2000WO2000075358A2 Mammalian toll homologues and uses thereof
12/14/2000WO2000075354A2 Adenoviral vectors encoding interferon and their use in gene therapy
12/14/2000WO2000075352A2 Hcv/bvdv chimeric genomes and uses thereof
12/14/2000WO2000075347A2 Tet repressor-based transcriptional regulatory proteins
12/14/2000WO2000075346A1 Fusion proteins comprising a fragment of a chaperon polypeptide
12/14/2000WO2000075345A1 Recombinant fusion protein, (vaccine) composition containing the same and method for the production thereof
12/14/2000WO2000075344A1 Pectate lyase fusion for expression and secretion of polypeptides
12/14/2000WO2000075342A1 Novel plasmid vector
12/14/2000WO2000075338A2 CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF
12/14/2000WO2000075337A1 INFECTIOUS cDNA CLONE OF GB VIRUS B AND USES THEREOF
12/14/2000WO2000075336A2 Polyepitopic proteinic fragments of e6 and e7 hpv proteins, production and use thereof in vaccines
12/14/2000WO2000075335A2 Bacteriophage rm 378 of a thermophilic host organism
12/14/2000WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000WO2000075332A2 USE OF THE REGULATORY SUBUNIT OF THE CAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS
12/14/2000WO2000075331A1 Compositions affecting programmed cell death and their use in the modification of forestry plant development
12/14/2000WO2000075330A1 Use of the bnm3 transcriptional activator to control plant embryogenesis and regeneration processes
12/14/2000WO2000075329A1 Targeted angiogenesis
12/14/2000WO2000075328A1 Human sel-10 polypeptides and polynucleotides that encode them
12/14/2000WO2000075327A1 Methods and compositions for inhibiting neoplastic cell growth
12/14/2000WO2000075326A1 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use
12/14/2000WO2000075325A1 Lifeguard (lfg) polynucleotides and polypeptides and methods of use thereof
12/14/2000WO2000075324A2 Recombinant prion-like genes and proteins and materials and methods comprising same
12/14/2000WO2000075323A1 Tek antagonists
12/14/2000WO2000075322A1 Insect monoamine transporter and methods of use thereof
12/14/2000WO2000075321A2 Polynucleotides and membrane-bound polypeptide encoded thereby
12/14/2000WO2000075320A2 Human genes and proteins encoded thereby
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075316A1 Methods and compositions for inhibiting neoplastic cell growth
12/14/2000WO2000075315A1 Novel transporter gene expressed in liver
12/14/2000WO2000075314A1 Novel hemopoietin receptor protein nr10
12/14/2000WO2000075313A1 Method for judging rheumatoid arthritis
12/14/2000WO2000075312A1 Cd44 splice variant associated with rheumatoid arthritis
12/14/2000WO2000075311A1 Recombinant nematode nicotinic receptor and uses
12/14/2000WO2000075310A1 Interleukin-1-receptor associated kinase-3 (irak3)
12/14/2000WO2000075309A1 Spliceosome protein and its use
12/14/2000WO2000075308A1 Muteins of bilin-binding protein
12/14/2000WO2000075307A1 Hygromycin tolerance gene and transformed yeast belonging to the genus candida
12/14/2000WO2000075305A2 Candida albicans genes and proteins coded by said genes
12/14/2000WO2000075300A2 Methods for manipulating the avian genome
12/14/2000WO2000075298A2 Molecules for disease detection and treatment
12/14/2000WO2000075280A2 A member of the frzb family, frazzled
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075278A2 Gene encoding nade, p75ntr-associated cell death executor and uses thereof
12/14/2000WO2000075189A1 Stabilized denatured lipoprotein and process for producing the same
12/14/2000WO2000075188A1 Method of measuring plasma membrane targeting of glut4
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075185A1 Bone stimulating factor
12/14/2000WO2000075184A1 Modulation of protein levels using the scf complex
12/14/2000WO2000075183A1 Product from starfish
12/14/2000WO2000075182A1 Crystal of ribosomal recycling factor (rrf) protein and application thereof on the basis of three-dimensional structural data obtained from the crystal
12/14/2000WO2000075181A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
12/14/2000WO2000075180A2 Peptides for vaccinating against human cmv
12/14/2000WO2000075176A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075173A2 Peptide fragments of colostrinin
12/14/2000WO2000075171A1 Process for the preparation of supports for solid phase synthesis
12/14/2000WO2000075168A1 Mouse urotensin-ii receptor (utb-r)
12/14/2000WO2000075166A1 Melanin concentrating hormone receptor
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075161A2 Compositions and methods for the screening of compounds to enhance or reduce apoptosis
12/14/2000WO2000074728A1 Novel reagents for detection and purification of antibody fragments
12/14/2000WO2000074726A1 METHODS AND COMPOSITIONS FOR PREVENTING p53 MEDIATED APOPTOSIS
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074721A1 Vitamin directed dual targeting therapy
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074704A1 Transcription factors related to tfiia
12/14/2000WO2000074630A2 Dna vaccine for protecting an avian against infectious bursal disease virus
12/14/2000WO2000054651A3 Human tumor necrosis factor receptor-like genes
12/14/2000WO2000053776A3 Human kallikrein-like genes
12/14/2000WO2000053749A3 Vascular adhesion molecules and modulation of their function
12/14/2000WO2000050588A3 Genes associated with diseases of the colon
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000049040A3 Antimicrobial/endotoxin neutralizing polypeptide
12/14/2000WO2000049039A3 Glucose dehydrogenase fusion proteins and their utilization in expression systems
12/14/2000WO2000047714A3 Isolation and characterization of heat shock protein
12/14/2000WO2000047612A3 Structure-based screening techniques for drug discovery
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
12/14/2000WO2000046241A3 Prostate, testis and uterine polypeptide zpep14
12/14/2000WO2000046236A3 Novel rgs-containing molecules and uses thereof
12/14/2000WO2000044399A3 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000042063A3 Peptides for inhibiting hbv core proteins
12/14/2000WO2000033872A9 Method of and compositions for immunization with the pseudomonas v antigen
12/14/2000WO2000010589A9 Somatostatin analogs
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000DE19926771A1 Nukleinsäuremoleküle aus Weizen, transgene Pflanzenzellen und Pflanzen und deren Verwendung für die Herstellung modifizierter Stärke Nucleic acid molecules from wheat, transgenic plant cells and plants and their use for the production of modified starch
12/14/2000CA2588221A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000CA2504679A1 Compositions and methods for the treatment of tumor
12/14/2000CA2501815A1 Compositions and methods for the treatment of tumor
12/14/2000CA2390090A1 Peptides